AAREYDRUGS
Start SIP
Invest Now
Start SIP in AAREYDRUGS
Performance
- Low
- ₹66
- High
- ₹68
- 52 Week Low
- ₹31
- 52 Week High
- ₹100
- Open Price₹66
- Previous Close₹66
- Volume366,773
Investment Returns
- Over 1 Month -14.22%
- Over 3 Month -17.76%
- Over 6 Month -6.63%
- Over 1 Year + 13.44%
Smart Investing Starts Here Start SIP with Aarey Drugs & Pharmaceuticals for Steady Growth!
Aarey Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 53.5
- PEG Ratio
- -1.3
- Market Cap Cr
- 192
- P/B Ratio
- 1.3
- Average True Range
- 3.55
- EPS
- 1.26
- Dividend Yield
- 0
- MACD Signal
- -4.38
- RSI
- 32.4
- MFI
- 71.76
Aarey Drugs & Pharmaceuticals Financials
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹67.62
+
1.28
(1.93%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹71.21
- 50 Day
- ₹76.70
- 100 Day
- ₹76.14
- 200 Day
- ₹70.61
Resistance and Support
66.26
- R3 69.96
- R2 68.70
- R1 67.52
- S1 65.08
- S2 63.82
- S3 62.64
Aarey Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results | |
| 2024-12-04 | To consider Fund Raising |
Aarey Drugs & Pharmaceuticals F&O
About Aarey Drugs & Pharmaceuticals
- NSE Symbol
- AAREYDRUGS
- BSE Symbol
- 524412
- Chairman & Managing Director
- Mr. Mihir R Ghatalia
- ISIN
- INE198H01019
Similar Stocks to Aarey Drugs & Pharmaceuticals
Aarey Drugs & Pharmaceuticals FAQs
Aarey Drugs & Pharmaceuticals share price is ₹67 As on 05 January, 2026 | 16:53
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹191.7 Cr As on 05 January, 2026 | 16:53
The P/E ratio of Aarey Drugs & Pharmaceuticals is 53.5 As on 05 January, 2026 | 16:53
The PB ratio of Aarey Drugs & Pharmaceuticals is 1.3 As on 05 January, 2026 | 16:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.